The impacts of the COVID-19 pandemic on indirect costs of mental illness and behavioral disorders in Poland.
COVID-19
absenteeism
behavioral disorders
indirect costs
mental illness
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
25
05
2023
accepted:
30
08
2023
medline:
5
10
2023
pubmed:
4
10
2023
entrez:
4
10
2023
Statut:
epublish
Résumé
In various research, the estimation of the disease's economic burden has been taken into consideration. But given the fact that different settings will have distinguished consequences, determining the economic burden of COVID-19 in the studied environment is of great importance. As a result, this study aimed to show the change in indirect costs of mental health problems due to the COVID-19 pandemic in Poland. Indirect costs related to mental health problems were analyzed from the perspective of the Social Insurance Institution in Poland. In 2021, they amounted to about 285.8 billion PLN (Polish currency) [61.1 billion EUR (European currency)], up 6% from the previous year. A large increase in spending on disability benefits was observed for 2019-2021 (+14.7%). Disease groups generating the highest expenditures in the structure of total expenditures on incapacity benefits in 2021 in Poland were mental health problems (16.7% of total expenditures). Expenditures on disability benefits related to mental health problems incurred by Social Security in 2021 amounted to about 7.42 billion PLN [1.6 billion EUR] and were 19.4% higher than in 2019 (before the pandemic). In the 2012-2019 period, there was a significant decrease in expenses related to inpatient rehabilitation (41.3%), while in 2020-2021, these expenses decreased several times as the epidemiological situation related to the COVID pandemic reduced access to such services. This is the first study on the economic burden of COVID-19 indirect costs in Poland. Calculating the economic impact is crucial, particularly when there is a large disease outbreak and countries are severely constrained by financial resources. Doing so could aid in the development of effective social security policies. As shown in this study, the indirect costs of absenteeism expenses due to mental health problems increased significantly during the COVID-19 pandemic. It is necessary to take all possible measures, both in the field of primary and secondary prevention, to prevent disability and exclusion from the labor market of people affected by mental health problems, which is justified by epidemiological data and financial data on the expenses incurred by Social Security for social insurance benefits.
Identifiants
pubmed: 37790719
doi: 10.3389/fpubh.2023.1207389
pmc: PMC10544582
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1207389Informations de copyright
Copyright © 2023 Sobczyk, Holecki and Rogalska.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Asian J Psychiatr. 2020 Jun;51:102051
pubmed: 32298968
Workplace Health Saf. 2023 Feb;71(2):58-67
pubmed: 36382962
J Med Econ. 2021 Jan-Dec;24(1):308-317
pubmed: 33555956
Brain Behav Immun. 2020 Aug;88:17-27
pubmed: 32416290
J Infect Dev Ctries. 2021 Sep 30;15(9):1263-1272
pubmed: 34669594
Int J Surg. 2020 Jun;78:185-193
pubmed: 32305533
Psychiatry Res. 2020 May;287:112922
pubmed: 32203749
BMC Health Serv Res. 2021 Feb 11;21(1):132
pubmed: 33573650
Br J Psychiatry. 2018 Dec;213(6):716-722
pubmed: 30301477
BMC Geriatr. 2021 Nov 19;21(1):650
pubmed: 34798817
J Family Med Prim Care. 2020 Oct 30;9(10):5103-5106
pubmed: 33409171
Inquiry. 2022 Jan-Dec;59:469580221144398
pubmed: 36572983
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33277297
Lancet. 2020 Mar 14;395(10227):848-850
pubmed: 32151326
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
Asian J Psychiatr. 2020 Jun;51:102041
pubmed: 32315966
Clin Infect Dis. 2020 Dec 15;71(12):3182-3187
pubmed: 32594160
J Behav Cogn Ther. 2020 Sep;30(3):161-163
pubmed: 32954371
Am J Epidemiol. 2018 Nov 1;187(11):2339-2345
pubmed: 29955769
PLoS One. 2020 Oct 27;15(10):e0241030
pubmed: 33108381
Soc Psychiatry Psychiatr Epidemiol. 2018 Sep;53(9):977-986
pubmed: 29992341
Nat Commun. 2020 Oct 8;11(1):5064
pubmed: 33033249
Int J Environ Res Public Health. 2021 Jun 27;18(13):
pubmed: 34199100
BMC Infect Dis. 2020 Nov 16;20(1):853
pubmed: 33198725
Front Psychiatry. 2023 Mar 16;14:1139260
pubmed: 37009102
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
J Hosp Infect. 2021 Aug;114:126-133
pubmed: 33894306
Glob Public Health. 2020 Jul;15(7):1083-1089
pubmed: 32352911
Infect Chemother. 2020 Dec;52(4):496-502
pubmed: 33263246
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):853-858
pubmed: 32644979
BMC Health Serv Res. 2021 Oct 28;21(1):1169
pubmed: 34711242
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Eur Child Adolesc Psychiatry. 2020 Jun;29(6):749-758
pubmed: 32363492
Epidemiol Health. 2020;42:e2020038
pubmed: 32512661
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512